Trident Texofab Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 08:02 pm
13-11-2025 | 08:02 pm
Trident Texofab's board approved Q2 & H1 2025 financial results. Q2 revenue hit ₹30.63 Cr with ₹1.13 Cr net profit. For H1, revenue was ₹58.71 Cr, and net profit reached ₹2.14 Cr.
No comments yet. Be the first to comment!
